Pharmacoepidemiology and Drug Safety

Cover image for Vol. 25 Issue 4

Early View (Online Version of Record published before inclusion in an issue)

Edited By: B.L. Strom, USA; S. Hennessy, USA; H. G. M. Leufkens, The Netherlands; B.J. Park, Korea

Impact Factor: 2.939

ISI Journal Citation Reports © Ranking: 2014: 86/255 (Pharmacology & Pharmacy)

Online ISSN: 1099-1557


  1. 1 - 53
  1. Original Reports

    1. Switch-backs associated with generic drugs approved using product-specific determinations of therapeutic equivalence

      Joshua J. Gagne, Jennifer M. Polinski, Wenlei Jiang, Sarah K. Dutcher, Jing Xie, Joyce Lii, Lisa A. Fulchino and Aaron S. Kesselheim

      Article first published online: 22 APR 2016 | DOI: 10.1002/pds.4009

    2. You have full text access to this OnlineOpen article
      The experience of accommodating privacy restrictions during implementation of a large-scale surveillance study of an osteoporosis medication

      Kirk D. Midkiff, Elizabeth B. Andrews, Alicia W. Gilsenan, Dennis M. Deapen, David H. Harris, Maria J. Schymura and Francis J. Hornicek

      Article first published online: 19 APR 2016 | DOI: 10.1002/pds.4008

    3. Characteristics of state prescription drug monitoring programs: a state-by-state survey

      A. Travis Manasco, Christopher Griggs, Rebecca Leeds, Breanne K. Langlois, Alan H Breaud, Patricia M. Mitchell and Scott G. Weiner

      Article first published online: 8 APR 2016 | DOI: 10.1002/pds.4003

    4. Post licensure surveillance of influenza vaccines in the Vaccine Safety Datalink in the 2013–2014 and 2014–2015 seasons

      Rongxia Li, Brock Stewart, Michael M. McNeil, Jonathan Duffy, Jennifer Nelson, Alison Tse Kawai, Roger Baxter, Edward A. Belongia and Eric Weintraub

      Article first published online: 1 APR 2016 | DOI: 10.1002/pds.3996

    5. Postmenopausal hormone therapy in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): who still uses it?

      Estela M. L. Aquino, Maria-da-Conceição C. Almeida, Greice M. S. Menezes, Roberta Carvalho de Figueiredo, Isabela M. Bensenor, Sotero Serrate Mengue, Maria de Jesus M. da Fonseca and Ligia Gabrielli

      Article first published online: 29 MAR 2016 | DOI: 10.1002/pds.3992

    6. Psychotropic drugs and risk of burn injury in individuals with mental illness: a 10-year population-based case–control study

      Chia-Ming Chang, Kuan-Yi Wu, Yu-Wen Chiu, Hsiao-Ting Wu, Yu-Ting Tsai, Yeuk-Lun Chau and Hui-Ju Tsai

      Article first published online: 28 MAR 2016 | DOI: 10.1002/pds.3995

    7. How to take into account exposure to drugs over time in pharmacoepidemiology studies of pregnant women?

      Caroline Hurault-Delarue, Cécile Chouquet, Nicolas Savy, Isabelle Lacroix, Anna-Belle Beau, Jean-Louis Montastruc and Christine Damase-Michel

      Article first published online: 27 MAR 2016 | DOI: 10.1002/pds.4000

    8. New depression diagnosis following prescription of codeine, hydrocodone or oxycodone

      Jeffrey F. Scherrer, Joanne Salas, Kathleen K. Bucholz, F. David Schneider, Thomas Burroughs, Laurel A. Copeland, Mark D. Sullivan and Patrick J. Lustman

      Article first published online: 22 MAR 2016 | DOI: 10.1002/pds.3999

    9. Appropriate baseline laboratory testing following ACEI or ARB initiation by Medicare FFS beneficiaries

      Matthew L. Maciejewski, Bradley G. Hammill, Laura G. Qualls, Susan N. Hastings, Virginia Wang and Lesley H. Curtis

      Article first published online: 15 MAR 2016 | DOI: 10.1002/pds.3994

    10. Patterns and prevalence of medication use across the menstrual cycle among healthy, reproductive aged women

      Kristen A. Johnson, Lindsey A. Sjaarda, Sunni L. Mumford, Rebecca A. Garbose, Karen C. Schliep, Donald Mattison, Neil J. Perkins, Jean Wactawski-Wende and Enrique F. Schisterman

      Article first published online: 8 MAR 2016 | DOI: 10.1002/pds.3993

  2. Brief Reports

    1. Current needs in pediatric pharmacoepidemiology

      Tamar Lasky, Al Artaman, Angela S. Czaja, Sonia S. Maruti, Osemeke U. Osokogu, Katia M.C. Verhamme and Rachel E. Sobel

      Article first published online: 22 FEB 2016 | DOI: 10.1002/pds.3985

  3. Original Reports

    1. Prescription patterns of antiepileptic drugs in young women: development of a tool to distinguish between epilepsy and psychiatric disorders

      Ilaria Naldi, Carlo Piccinni, Barbara Mostacci, Jessica Renzini, Gabriele Accetta, Francesca Bisulli, Maria Tappatà, Antonella Piazza, Paola Pagano, Stefano Bianchi, Roberto D'Alessandro, Paolo Tinuper, Elisabetta Poluzzi and ESPEA (Emilia-Romagna Study on Pregnancy and Exposure to Antiepileptic drugs) Group

      Article first published online: 17 FEB 2016 | DOI: 10.1002/pds.3984

    2. Effects of breast cancer on chronic disease medication adherence among older women

      Melissa L. Santorelli, Michael B. Steinberg, Kim M. Hirshfield, George G. Rhoads, Elisa V. Bandera, Yong Lin and Kitaw Demissie

      Article first published online: 15 FEB 2016 | DOI: 10.1002/pds.3971

    3. Changes in the medical management of patients on opioid analgesics following a diagnosis of substance abuse

      Leonard J. Paulozzi, Chao Zhou, Christopher M. Jones, Likang Xu and Curtis S. Florence

      Article first published online: 10 FEB 2016 | DOI: 10.1002/pds.3980

    4. Completeness of serious adverse drug event reports received by the US Food and Drug Administration in 2014

      Thomas J. Moore, Curt D. Furberg, Donald R. Mattison and Michael R. Cohen

      Article first published online: 10 FEB 2016 | DOI: 10.1002/pds.3979

    5. Agreement between Medicare pharmacy claims, self-report, and medication inventory for assessing lipid-lowering medication use

      Lisandro D. Colantonio, Shia T. Kent, Meredith L. Kilgore, Elizabeth Delzell, Jeffrey R. Curtis, George Howard, Monika M. Safford and Paul Muntner

      Article first published online: 29 JAN 2016 | DOI: 10.1002/pds.3970

    6. Stimulant use for ADHD and relative age in class among children in Israel

      Moshe B. Hoshen, Arriel Benis, Katherine M. Keyes and Helga Zoëga

      Article first published online: 29 JAN 2016 | DOI: 10.1002/pds.3962

    7. You have full text access to this OnlineOpen article
      One-year mortality associated with COPD treatment: a comparison of tiotropium and long-acting beta2-agonists in three Italian regions: results from the OUTPUL study

      Ursula Kirchmayer, Silvia Cascini, Nera Agabiti, Mirko Di Martino, Lisa Bauleo, Giulio Formoso, Claudio Voci, Riccardo Pistelli, Elisabetta Patorno, Marina Davoli and on behalf of the OUTPUL study group

      Article first published online: 29 JAN 2016 | DOI: 10.1002/pds.3961

  4. Commentaries

  5. Original Reports

    1. Risk of arteriovenous fistula failure associated with hypnotic use in hemodialysis patients: a nested case-control study

      Chao-Feng Lin, Hung-Yi Chiou, Ya-Hui Chang, Ju-Chi Liu, Yen-Ni Hung, Ming-Tsang Chuang and Li-Nien Chien

      Article first published online: 22 JAN 2016 | DOI: 10.1002/pds.3963

    2. Trends in the use of maintenance immunosuppressive drugs among liver transplant recipients in Taiwan: a nationwide population-based study

      Ying-Yu Huang, Chia-Chen Hsu, Chia-Lin Chou, Che-Chuan Loong, Min-Shan Wu and Yueh-Ching Chou

      Article first published online: 22 JAN 2016 | DOI: 10.1002/pds.3964

    3. Patient population with multiple myeloma and transitions across different lines of therapy in the USA: an epidemiologic model

      Javier Cid Ruzafa, Evie Merinopoulou, Rebecca F. Baggaley, Pamela Leighton, Winifred Werther, Diana Felici and Andrew Cox

      Article first published online: 19 JAN 2016 | DOI: 10.1002/pds.3927

    4. The extent and correlates of community-based pharmaceutical opioid utilisation in Australia

      Louisa Degenhardt, Natasa Gisev, Elena Cama, Suzanne Nielsen, Briony Larance and Raimondo Bruno

      Article first published online: 19 JAN 2016 | DOI: 10.1002/pds.3931

    5. Effectiveness of bevacizumab exposure beyond disease progression in patients with non–small-cell lung cancer: analyses of the ARIES observational cohort study

      Larry Leon, Michael Kosty, Mohammad Jahanzeb, David Spigel, Antoinette J. Wozniak, Julie Brahmer, Susan Fish, E. Dawn Flick, Sebastien J. Hazard and Thomas J. Lynch

      Article first published online: 8 JAN 2016 | DOI: 10.1002/pds.3948

    6. You have full text access to this OnlineOpen article
  6. Commentaries

    1. The prescription paradox of acetaminophen safety

      Richard C. Dart and Jody L. Green

      Article first published online: 29 DEC 2015 | DOI: 10.1002/pds.3930

  7. Original Reports

    1. Increasing use of prescription drugs in the United Kingdom

      Frank Zhang, Ronac Mamtani, Frank I. Scott, David S. Goldberg, Kevin Haynes and James D. Lewis

      Article first published online: 29 DEC 2015 | DOI: 10.1002/pds.3947

    2. Trends in prescribing of sedative-hypnotic medications in the USA: 1993–2010

      Christopher N. Kaufmann, Adam P. Spira, G. Caleb Alexander, Lainie Rutkow and Ramin Mojtabai

      Article first published online: 29 DEC 2015 | DOI: 10.1002/pds.3951

  8. Brief Reports

    1. A synthesis of oral morphine equivalents (OME) for opioid utilisation studies

      Suzanne Nielsen, Louisa Degenhardt, Bianca Hoban and Natasa Gisev

      Article first published online: 22 DEC 2015 | DOI: 10.1002/pds.3945

  9. Original Reports

    1. Copayments for prescription medicines on a public health insurance scheme in Ireland

      Sarah-Jo Sinnott, Charles Normand, Stephen Byrne, Noel Woods and Helen Whelton

      Article first published online: 22 DEC 2015 | DOI: 10.1002/pds.3917

  10. Brief Reports

    1. Pediatric registries at the Food and Drug Administration: design aspects that increase their likelihood of success

      Scott K. Winiecki, M. Isabel Tejero-Taldo, Debbie Avant, Dianne Murphy and Ann W. McMahon

      Article first published online: 21 DEC 2015 | DOI: 10.1002/pds.3939

  11. Original Reports

    1. Developing alerting thresholds for prospective drug safety monitoring

      Grace Wangge, Sebastian Schneeweiss, Robert J. Glynn and Joshua J. Gagne

      Article first published online: 24 NOV 2015 | DOI: 10.1002/pds.3905

    2. Stimulant use following the publicity of cardiovascular safety and the introduction of patient medication guides

      Chih-Ying Chen, Regina Bussing, Abraham G. Hartzema, Jonathan J. Shuster, Richard Segal and Almut G. Winterstein

      Article first published online: 23 NOV 2015 | DOI: 10.1002/pds.3894

    3. You have full text access to this OnlineOpen article
      Prospective influenza vaccine safety surveillance using fresh data in the Sentinel System

      Weiling Katherine Yih, Martin Kulldorff, Sukhminder K. Sandhu, Lauren Zichittella, Judith C. Maro, David V. Cole, Robert Jin, Alison Tse Kawai, Meghan A. Baker, Chunfu Liu, Cheryl N. McMahill-Walraven, Mano S. Selvan, Richard Platt, Michael D. Nguyen and Grace M. Lee

      Article first published online: 17 NOV 2015 | DOI: 10.1002/pds.3908

    4. Regulatory anticipation of postmarket safety problems for novel medicines approved by the EMA between 2001 and 2010: a cross-sectional study

      Jean-David Zeitoun, Jérémie H. Lefèvre, Nicholas S. Downing, Henri Bergeron and Joseph S. Ross

      Article first published online: 11 NOV 2015 | DOI: 10.1002/pds.3910

    5. Trends in rates of acetaminophen-related adverse events in the United States

      Jacqueline M. Major, Esther H. Zhou, Hui-Lee Wong, James P. Trinidad, Tracy M. Pham, Hina Mehta, Yulan Ding, Judy A. Staffa, Solomon Iyasu, Cunlin Wang and Mary E. Willy

      Article first published online: 3 NOV 2015 | DOI: 10.1002/pds.3906

  12. Abstracts


  1. 1 - 53